IQP-AK-102

DEVICE3 trials

Sponsors

InQpharm Group

Conditions

Appetite Modulation (Focus of Study)Appetite RegulationAppetite SuppressionEnergy IntakeWeight Loss

Phase 3

Safety and Efficacy of IQP- AK-102 in Reducing Body Weight

CompletedNCT01905956

InQpharm GroupWeight Loss

Start: 2013-07-31End: 2014-07-31Updated: 2016-03-08

Safety and Efficacy of IQP-AK-102 in Reducing Appetite

CompletedNCT02041754

InQpharm GroupAppetite Modulation (Focus of Study), Weight Loss

Start: 2014-01-31End: 2014-08-31Updated: 2015-03-25

Unknown Phase

Efficacy and Safety of IQP-AK-102 in Reducing Appetite

CompletedNCT02774486

InQpharm GroupAppetite Regulation, Appetite Suppression, Energy Intake

Start: 2016-05-01End: 2016-07-20Updated: 2018-01-03